atazanavir sulfate has been researched along with dapsone in 1 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (dapsone) | Trials (dapsone) | Recent Studies (post-2010) (dapsone) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 5,116 | 379 | 862 |
Protein | Taxonomy | atazanavir sulfate (IC50) | dapsone (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 0.42 | |
Dihydrofolate reductase | Pneumocystis carinii | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanton, LS; East, J | 1 |
1 other study(ies) available for atazanavir sulfate and dapsone
Article | Year |
---|---|
Symptomatic hyperbilirubinemia secondary to dapsone-induced hemolysis and atazanavir therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia, Hemolytic; Anti-HIV Agents; Anti-Infective Agents; Atazanavir Sulfate; Dapsone; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Male; Middle Aged; Oligopeptides; Pneumocystis carinii; Pneumonia, Pneumocystis; Pyridines | 2012 |